A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus

NCT02954601 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ORMD-0801 (qd)
DRUG: ORMD-0801 (bid)
DRUG: ORMD-0801 (tid)
OTHER: Placebo

Sponsor

Oramed, Ltd.

Collaborators

[object Object]